United States · FDA National Drug Code directory
Briviact
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50474-770_597ca2bd-7caa-0d00-e063-6394a90a00c7
- Product NDC
- 50474-770
- Form
- TABLET, FILM COATED
- Composition / generic term
- brivaracetam
- Labeler
- UCB, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20160512
- Source listing expiry
- 20271231
Source-listed ingredients
- BRIVARACETAM — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 BLISTER PACK in 1 CARTON (50474-770-09) / 1 TABLET, FILM COATED in 1 BLISTER PACK · 50474-770-09
- 1 BLISTER PACK in 1 CARTON (50474-770-14) / 14 TABLET, FILM COATED in 1 BLISTER PACK · 50474-770-14
- 1 BOTTLE in 1 CARTON (50474-770-66) / 60 TABLET, FILM COATED in 1 BOTTLE · 50474-770-66
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →